[HTML][HTML] Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F

…, I Leshchiner, JF Gainor, S Bergqvist… - … England Journal of …, 2016 - Mass Medical Soc
… Shown is the patient’s second response after she had … to 250 mg twice daily once the patient’s
liver-function tests showed … and led to the patient’s relapse. Lorlatinib was effective against …

Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth

…, J Marakovits, S Karlicek, S Bergqvist… - Proceedings of the …, 2010 - National Acad Sciences
Despite abundant evidence that aberrant Rho-family GTPase activation contributes to most
steps of cancer initiation and progression, there is a dearth of inhibitors of their effectors (eg, …

Spectrum and degree of CDK drug interactions predicts clinical performance

…, W Hu, M Xu, RA Ferre, H Lam, S Bergqvist… - Molecular cancer …, 2016 - AACR
… In summary, the shape complementarity of dinaciclib in pCDK2′s ATP binding pocket,
along with the unique hinge sequence of CDK2, provide a structural rationale for the high …

Antimicrobial treatment of chronic osteomyelitis.

JT Mader, ME Shirtliff, SC Bergquist… - … and Related Research …, 1999 - journals.lww.com
… Factors involved in choosing the appropriate antibiotic(s) include infection type, infecting …
Once the infecting organism(s) is isolated and sensitivities are established, the initial antibiotic(s

Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance

…, P Kuzmic, J Solowiej, S Bergqvist… - Proceedings of the …, 2014 - National Acad Sciences
… 10 5 –10 7 M −1 s −1 ), despite their low specific reactivity (k inact ≤ 2.1 × 10 −3 s −1 ),
which is … One reversible interaction is between EGFR-Cys 797 nucleophile and the inhibitor’s

Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity

…, VA Love, PD Lira, R Doyonnas, S Bergqvist… - Cancer Immunology …, 2012 - Springer
4-1BB (CD137, TNFRSF9) is a costimulatory receptor expressed on several subsets of
activated immune cells. Numerous studies of mouse and human T cells indicate that 4-1BB …

[PDF][PDF] Structure of HIV-1 reverse transcriptase with the inhibitor β-thujaplicinol bound at the RNase H active site

…, K Ryan, MJ Hickey, RA Love, SH Hughes, S Bergqvist… - Structure, 2009 - cell.com
… Subsequent binding of substrate would then trap the E$S$I complex. This could explain the
… $S complex is slow relative to both the formation of the E$I complex and turnover of the E$S

[HTML][HTML] Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases

L Mallbris, P Larsson, S Bergqvist, E Vingård… - Journal of investigative …, 2005 - Elsevier
Psoriasis is clinically a heterogeneous disease. Detailed evaluation of phenotype at disease
onset is lacking. This study is a baseline characterization of 400 adult individuals with first …

Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies

…, K Amundson, R Simon, A Erbersdobler, S Bergqvist… - Cancer research, 2011 - AACR
Genetic and molecular studies suggest that activin receptor-like kinase 1 (ALK1) plays an
important role in vascular development, remodeling, and pathologic angiogenesis. Here we …

The contribution of cytosine protonation to the stability of parallel DNA triple helices

JL Asensio, AN Lane, J Dhesi, S Bergqvist… - Journal of molecular …, 1998 - Elsevier
… in the ‘S’ domain, and that the mole fraction of the ‘S’ conformers for the purines is high (>
90%). Similar results were obtained with the other triplexes (data not shown). This information, …